<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR139">
 <label>139.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weinblatt</surname>
    <given-names>ME</given-names>
   </name>
   <name>
    <surname>Keystone</surname>
    <given-names>EC</given-names>
   </name>
   <name>
    <surname>Furst</surname>
    <given-names>DE</given-names>
   </name>
   <name>
    <surname>Moreland</surname>
    <given-names>LW</given-names>
   </name>
   <name>
    <surname>Weisman</surname>
    <given-names>MH</given-names>
   </name>
   <name>
    <surname>Birbara</surname>
    <given-names>CA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial</article-title>
  <source>Arthritis Rheum</source>
  <year>2003</year>
  <volume>48</volume>
  <fpage>35</fpage>
  <lpage>45</lpage>
  <pub-id pub-id-type="doi">10.1002/art.10697</pub-id>
  <?supplied-pmid 12528101?>
  <pub-id pub-id-type="pmid">12528101</pub-id>
 </element-citation>
</ref>
